Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine & Amitriptyline in Refractory Chronic Cough
NCT05110144Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Nov 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine, amitriptyline in refractory chronic cough (RCC), sponsored by Mayo Clinic. Started Nov 2021; status: recruiting.
02
Drugs
duloxetineamitriptyline
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on NCT05110144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110144.